Lessons on the Second Cancers Resulting from Cancer Chemotherapy

  • Bernard D. Goldstein
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 283)


In this paper we explore some of the insights into the mechanisms of human carcinogenesis and into the assessment of cancer risk that could be obtained by the study of individuals at risk of development of a second cancer due to treatment with chemotherapeutic agents. We urge a concerted effort to study the processes by which cancer chemotherapeutic agents result in the production of a second cancer.


Acute Myeloid Leukemia Latency Period Cold Spring Harbor Alkylating Agent Acute Myelogenous Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aksoy, M. (1989). Hematotoxicity and carcinogenicity of benzene. Env. Health Perspectives 82, 193–197.CrossRefGoogle Scholar
  2. Blayney, D.W., Longo, D.L., Young R.C., Greene, M.H., Hubbard, S.M., Postal, M.G., Duffey, P.L. and Devita, JR., V.T. (1987). Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. NEJM 316, 710–714.Google Scholar
  3. Brill, B., Tomonaga, M. and Heyssel, R.M. (1962). Leukemia in man following exposure to ionizing radiation. Ann. Intern. Med. 56, 590–609.PubMedGoogle Scholar
  4. Calabresi, P. and Parks Jr., R.E. (1985). Antiproliferative agents and drugs used for immunosuppression. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics ( L.S. Goodman, T.W. Rall and F. Murad, Eds.). pp. 1247–1306. MacMillan Publishing Company, New York.Google Scholar
  5. Coleman, C.N., Kaplan, H.S., Cox, R., Varghese, A., Butterfield, P. and Rosenberg, S.A. (1982). Leukemias, non-Hodgkin’s lymphomas and solid tumors in patients treated for Hodgkin’s disease. Cancer Surv. 3, 734–744.Google Scholar
  6. Colvin, M. (1982). The alkylating agents. In Pharmacologic Principles of Cancer Treatment ( B.A. Chabner, Ed.). pp. 276–308. W.B. Saunders Co., Philadelphia.Google Scholar
  7. Goldstein, B.D. (1989a). Occam’s razor is dull. Environ. Health Perspectives 82, 199–206.CrossRefGoogle Scholar
  8. Goldstein, B.D. (1989b). Clinical hematotoxicity of benzene. In Benzene: Occupational and Environmental Hazards-Scientific Update ( M.A. Mehlman, Ed.). pp. 55–65. Princeton Scientific Publishing Co., Inc., Princeton, NJ.Google Scholar
  9. Hoover, R. (1977). Effects of drugs: Immunosuppression. In Origins of Human Cancer (H.H. Hiatt, J.D. Wetson and J.A. Winsten, Eds.). pp. 369–379. Cold Spring Harbor Conferences on Cell Proliferation 4, Cold Spring Harbor, NY.Google Scholar
  10. Kaldor, J.M., Day, N.E., Pettersson, F., Clarke, E.A., et al. (1990a). Leukemia following chemotherapy for ovarian cancer. NEJM 322, 1–6.CrossRefPubMedGoogle Scholar
  11. Kaldor, J.M., Day, N.E., Clarke, E.A., Van Leeuwen, F.E., et al. (1990b). Leukemia following Hodgkin’s disease. NEJM 322, 7–13.CrossRefPubMedGoogle Scholar
  12. Kleinerman, R.A., Curtis, R.E., Boice Jr., J.D., Flannery, J.T. and Fraumeni Jr., J.F. (1982). Second cancers following radiotherapy for cervical cancer. J. Natl. Cancer Inst. 69, 1027–1033.PubMedGoogle Scholar
  13. Kohn, H.I. and Fry, R.J. (1984). Radiation carcinogenesis. NEJM 310, 504–511.CrossRefPubMedGoogle Scholar
  14. Linet, M.S. (1985). The leukemias: Epidemiologic Aspects. In Monographs in Epidemiology and Biostatistics, Volume 6, Oxford University Press, New York.Google Scholar
  15. Loescher, L.J., Welch-McCaffrey, D., Leigh, S.A., Hoffman, B. and Meyskens, F.L. (1989). Surviving adult cancers. Part 1: Physiologic effects. Annals of Internal Medicine 111, 411–432.Google Scholar
  16. Ludlum, D.B. and Tong, W.P. (1985). DNA modification by the nitrosoureas: Chemical nature and cellular repair. In Cancer Chemotherapy, Vol. II ( E.M. Muggia and M. Nishoff, Eds.). pp. 141–154. Martinus Nijhoff, Boston.Google Scholar
  17. Ludlum, D.B., Colinas, R.J., Kirk, M.C. and Mehta, J.R. (1988). Reaction of reduced metronidazole with guanosine to form an unstable adduct. Carcinogenesis 9, 593–596.CrossRefPubMedGoogle Scholar
  18. Moolgavkar, S.H., Dewanji, A. and Luebeck, G. (1989). Cigarette smoking and lung cancer: Reanalysis of the British Doctor’s Data. J. Natl. Cancer Inst. 81, 415–420.CrossRefPubMedGoogle Scholar
  19. National Academy of Sciences (1989). Biologic Markers in Reproductive Toxicology. National Academy Press, Washington D.C.Google Scholar
  20. Pedersen-Bjergaard J., Specht, L., Larsen, S.O. and Ersboll J. (1987). Risk of therapy-related leukaemia and preleukaemia after Hodgkin’s diseases. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 2, 83–88.CrossRefPubMedGoogle Scholar
  21. Penn, I. (1981). Second malignancies following radiotherapy or chemotherapy for cancer. In The Immunopharmacologic Effects of Radiation Therapy ( B. Serrou, C. Rosenfeld and J.B. Dubois, Eds.). pp. 415–437. Raven Press, New York.Google Scholar
  22. Pui, C-H., Behm, F.G., Raimondi, S.C., Dodge, R.K., George, S.L., Rivera, G.K., Mirro, J., Kalwinsky, D.K., Dahl, G.V., Murphy, S.B., Crist, W.M. and Williams, D.L. (1989). Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. NEJM 321, 136–142.CrossRefPubMedGoogle Scholar
  23. Sangeetha, P., Das, U.N., Koratkar, R. and Suryaprabha, P. (1990). Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radical Biol. & Med. 8, 15–19.CrossRefGoogle Scholar
  24. Selikoff, I.J., Hammond, E.L. and Seidman, H. (1979). Mortality experience of insulation workers in the USA and Canada 1943–1976. Ann. NY Acad. Sci. 330, 91–116.CrossRefPubMedGoogle Scholar
  25. Tucker, M.A., Coleman, C.N., Cox, R.S., Varghese, A. and Rosenberg, S.A. (1988). Risk of second cancers after treatment for Hodgkin’s disease. NEJM 318, 76–81.CrossRefPubMedGoogle Scholar
  26. Vogelstein B., et al. (1989). Genetic alterations accumulate during colorectal tumorigenesis. In Recessive Oncogenes and Tumor Suppression ( W. Cavenee, N. Hastle, E. Stanbridge, Eds.). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Bernard D. Goldstein
    • 1
    • 2
  1. 1.Department of Environmental and Community MedicineUMDNJ-Robert Wood Johnson Medical SchoolPiscatawayUSA
  2. 2.Environmental and Occupational Health Sciences InstituteUSA

Personalised recommendations